| Vaccine cohort | CLSA | ||
---|---|---|---|---|
Female | Male | Female | Male | |
(NÂ = 190) | (NÂ = 102) | (NÂ = 1928) | (NÂ = 1938) | |
Albumin (ALB), g/L | 42.5 ± 1.09 [-0.25**] | 42.8 ± 1.07 [- 0.4***] | 39.6 ± 1.07 [- 0.14***] | 39.7 ± 1.07 [- 0.15***] |
Alanine aminotransferase (ALT), U/L | 13.2 ± 1.60 [- 0.26**] | 15.0 ± 1.51 [- 0.45***] | 18.5 ± 1.45 [- 0.13***] | 21.4 ± 1.46 [- 0.23***] |
Creatinine (CREAT), µmol/L | 72.0 ± 1.27 [0.15] | 87.4 ± 1.32 [0.02] | 72.0 ± 1.21 [0.15***] | 91.2 ± 1.23 [0.16***] |
Ferritin (FERR), µg/L | 52.4 ± 2.19 [- 0.2*] | 78.7 ± 2.43 [- 0.22] | 104.5 ± 2.17 [- 0.04*] | 159.2 ± 2.22 [- 0.04] |
Thyroxine (T4), pmol/L | 16.4 ± 1.24 [- 0.02] | 15.7 ± 1.28 [0.26*] | 15.4 ± 1.19 [0.06**] | 14.9 ± 1.16 [0.04] |
Cholesterol (CHOL), mmol/L | 4.7 ± 1.25 [- 0.13] | 4.2 ± 1.26 [- 0.29*] | 5.3 ± 1.24 [- 0.09***] | 4.5 ± 1.27 [- 0.11***] |
High-density lipoprotein (HDL), mmol/L | 1.4 ± 1.30 [0.07] | 1.2 ± 1.31 [0.23] | 1.6 ± 1.33 [0.02] | 1.3 ± 1.34 [0.06*] |
Triglycerides (TRIG), mmol/L | 1.6 ± 1.51 [- 0.22*] | 1.8 ± 1.71 [- 0.51***] | 1.5 ± 1.58 [- 0.03] | 1.5 ± 1.65 [- 0.11***] |
Tumour necrosis factor (TNF)a, pg/mL | 11.2 ± 1.37 [0.19*] | 12.1 ± 1.42 [- 0.03] | 1.1 ± 1.43 [0.21***] | 1.1 ± 1.39 [0.23***] |
Interleukin 6 (IL-6)a, pg/mL | 3.0 ± 2.79 [0.14] | 2.9 ± 1.99 [0.05] | 2.3 ± 1.78 [0.16***] | 2.3 ± 1.77 [0.24***] |